The Europe Nasogastric Tube Market would witness market growth of 4.7% CAGR during the forecast period (2022-2028).
The expansion of the nasogastric tube market is anticipated to be driven by the rise in preterm births and the ageing population. Pediatric patients and premature deliveries account for most nasogastric tube usage, driving market expansion. Normal medical tape is traditionally used to secure nasogastric tubes instead of nasogastric tube holders. However, the demand for nasogastric tubes is growing due to increased neck injuries caused by accidents and facial injuries that result in swallowing impairment.
The NG tube can administer special nourishment and medication directly into the stomach. People may require tube feeding (enteral nutrition) if they are not receiving sufficient nutrients through oral feeding. This may be the case if their disease impacts their appetite or makes it difficult to chew or swallow. Occasionally, hospitalized patients need only supplemental nutrition to promote their recovery.
Cardiovascular disease claims the lives of almost 1.8 million individuals in the European Union (EU) and 3.9 million people throughout Europe. In addition, CVDs are responsible for 37% of all fatalities in the EU. Comparing Central and Eastern Europe to Northern, Southern, and Western Europe, the mortality rates from ischemic heart disease (IHD) and stroke are higher. Over 49 million persons in the EU are estimated to have CVD, making up the estimated 85 million total in Europe. In addition to the steady rise in the senior population, chronic diseases are becoming more prevalent in Europe. The ageing of the EU-27 population has several implications (those 85 years of age or older). The market for nasogastric tubes is therefore expected to expand in the region.
The Germany market dominated the Europe Nasogastric Tube Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $44.3 million by 2028. The UK market is anticipated to grow at a CAGR of 3.8% during (2022 - 2028). Additionally, The France market would exhibit a CAGR of 5.5% during (2022 - 2028).
Based on Indication, the market is segmented into Dysphagia, Chronic Kidney Disease, Inflammatory Bowel Disease (IBD), Esophageal Cancer, Stomach Cancer and Others. Based on Patient Type, the market is segmented into Adult, Geriatric and Pediatric. Based on Type, the market is segmented into Small-bore Feeding Tubes and Large-bore Feeding Tubes. Based on End-Use, the market is segmented into Hospitals & Nursing Homes and Home Care. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
Free Valuable Insights: The Worldwide Nasogastric Tube Market is Projected to reach USD 669.5 Million by 2028, at a CAGR of 5.2%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Becton, Dickinson and Company, Medtronic PLC, Cardinal Health, Inc., QMD, Angiplast Pvt. Ltd., Securmed Spa, Vygon SAS, Andersen Products, Inc. (Weiler Abrasives Group), Guangdong Baihe Medical Technology Co., Ltd. and Poly Medicure Ltd.
By Indication
By Patient Type
By Type
By End-Use
By Country
Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
Unique Offerings 